What is Morgan Stanley's price target for TSVT?

Morgan Stanley's latest stated price target for 2seventy bio Inc. (TSVT) is $13, from its action on Jul 28, 2023.

What is Morgan Stanley's rating on TSVT?

Morgan Stanley rates TSVT Equal-Weight, a neutral rating, as of Jul 28, 2023.

When did Morgan Stanley last change its view on TSVT?

On Jul 28, 2023, Morgan Stanley downgrades to Equal-Weight from Overweight, price target $25 to $13.

Morgan Stanley TSVT price target and rating history

Morgan Stanley rates 2seventy bio Inc. (TSVT) Equal-Weight with a $13 price target, as of its latest action on Jul 28, 2023. It has published 3 rating actions on TSVT since November 2021, including 0 upgrades and 1 downgrade.

Current rating: Equal-Weight
Price target: $13
Median target, all firms: Too few
Actions on TSVT: 3

Morgan Stanley price target on TSVT

Morgan Stanley price target on TSVT, each point a stated target, November 2021 to July 2023.

Every Morgan Stanley rating on TSVT

Jul 28, 2023
DowngradeMorgan Stanley downgrades to Equal-Weight from Overweight, price target $25 to $13
Nov 8, 2021
InitiateMorgan Stanley starts coverage at Overweight
Nov 8, 2021
InitiateMorgan Stanley starts coverage at Overweight, price target $72

Questions about Morgan Stanley and TSVT

What is Morgan Stanley's price target for TSVT?: Morgan Stanley's latest stated price target for 2seventy bio Inc. (TSVT) is $13, from its action on Jul 28, 2023.
What is Morgan Stanley's rating on TSVT?: Morgan Stanley rates TSVT Equal-Weight, a neutral rating, as of Jul 28, 2023.
When did Morgan Stanley last change its view on TSVT?: On Jul 28, 2023, Morgan Stanley downgrades to Equal-Weight from Overweight, price target $25 to $13.

More TSVT rating histories

All Morgan Stanley ratings TSVT news and filings Every analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.